P reeclampsia (PE), a serious hypertensive pregnancy disorder complicating 2% to 5% of all pregnancies, is characterized by new-onset hypertension along with de novo proteinuria after 20 weeks of gestation 1 or new-onset proteinuria that develops after 20 weeks in women with preexisting hypertension. Women with a history of PE have an increased risk to develop chronic hypertension and related cardiovascular morbidity and mortality. 2 PE is accompanied by concentric left ventricular remodeling along with diastolic dysfunction and reduced cardiac contractility.
P reeclampsia (PE), a serious hypertensive pregnancy disorder complicating 2% to 5% of all pregnancies, is characterized by new-onset hypertension along with de novo proteinuria after 20 weeks of gestation 1 or new-onset proteinuria that develops after 20 weeks in women with preexisting hypertension. Women with a history of PE have an increased risk to develop chronic hypertension and related cardiovascular morbidity and mortality. 2 PE is accompanied by concentric left ventricular remodeling along with diastolic dysfunction and reduced cardiac contractility. 3 Accumulating evidence exists that women who experienced PE differ from their counterparts with uneventful pregnancies by persisting abnormal left ventricular geometry and decreased diastolic function. [4] [5] [6] It may be that former patients with underlying susceptibility for cardiovascular disease (CVD) react to borderline blood pressure values by excessive cardiac remodeling that does not revert to normal after delivery. In this line of reasoning, the slight differences in left ventricular geometry and cardiac diastolic function may be an indication for an increased risk for chronic hypertension as an intermediate condition before later CVD. Therefore, we tested the hypothesis that increased measures of cardiac geometry and decreased cardiac function persisting for ≥6 months postpartum in normotensive women with a history of PE precede the development of later chronic hypertension.
Methods

Study Population
breastfeeding. Patients were asked to discontinue the use of oral contraceptives. After the postpartum screening, all women received biennially questionnaires designed to evaluate their health status and possible subsequent pregnancies. We excluded women with preexisting hypertension indicated by hypertension already present before 20 weeks pregnancy or hypertension still present at the time of postpartum screening (n=42). Hypertension is diagnosed as systolic blood pressure ≥140 mm Hg and/or diastolic blood pressure (DiasBP) ≥90 mm Hg, or when taking antihypertensive drugs. Women who did not complete or return any questionnaire were considered lost to follow-up. We took self-reported use of antihypertensive medication to define hypertension at follow-up.
Measurements
Ten hours before the measurement session, participants were asked to refrain from eating, drinking caffeine-or alcohol-containing beverages, and smoking. The measurement session started at 8:00 am in a temperature-controlled room (±24°C) with external disturbances kept to a minimum. Throughout the measurements, participants were lying on their back on a comfortable bed in a half-sitting position with their upperarm at heart height, while the whole arm was in a relaxed position. After an acclimatization period of 30 minutes, we recorded arterial blood pressure at 3-minute intervals for a period of 30 minutes using a semiautomatic oscillometric device (Dinamap Vital Signs Monitor 1846; Critikon, Tampa, FL) with a cuff size of 13 
Echocardiographic Measurements
We assessed cardiac structure and function using a phased-array echocardiographic Doppler system (Hewlett-Packard Sonos 2000 and 2500; Hewlett-Packard Company, Palo Alto, CA) and performed the 2-dimensional, M-mode, and Doppler echocardiography according to the guidelines of the American Society of Echocardiography. 9 All data were analyzed offline using specific software (Excelera, Philips, The Netherlands). Using M-mode in the parasternal longaxis view, we measured left ventricular end-diastolic and end-systolic diameters (LVEDd, LVESd, mm), as well as end-diastolic thickness of the interventricular septum (IVST, mm) and of the posterior wall (PWT, mm). We used the Devereux formula 10 to estimate left ventricular mass (LVM, g) and indexed for height in meters 2.7 . 11 Finally, we calculated relative wall thickness (RWT=(IVST+PWT)/LVEDd) and fractional shortening FS=(LVEDd-LVESd)/LVEDd.
Systolic Function
Left ventricular systolic function was evaluated as follows: heart rate (bpm) was obtained by taking the reciprocal of the mean of 3 to 5 consecutive RR-intervals on the ECG (seconds) multiplied by 60. The mean aortic velocity time integral was obtained from the average of the outer edge tracings of 3 to 5 consecutive continuous wave Doppler registrations of the aortic flow across the aortic valve. Stroke volume (SV, mL) was derived by velocity time integral×cross-sectional area of the aortic annulus in the parasternal long-axis view. Cardiac output (CO, L·min . Left ventricular end-diastolic volume (EDV, mL) and end-systolic volumes (ESV, mL) were estimated using the Teichholz formula. 12 Ejection fraction was calculated by EF (%)=((EDV−ESV)/(EDV))×100%.
Diastolic Function
Diastolic function was assessed from the transmitral flow pattern obtained by pulsed-wave Doppler echocardiography in the apical 4-chamber view. The pulsed-wave Doppler sample volume (5 mm) was carefully positioned at the tip of the mitral valve leaflets. The sweep rate was set at 50 mm·s −1 . E/A ratio was defined as the ratio of peak mitral flow velocity in early diastole (E) and that during atrial contraction (A). Doppler-derived indices were averaged over 3 to 5 consecutive cardiac cycles.
Total Peripheral Vascular Resistance
Total peripheral vascular resistance (dynes·s·cm −5 ) was obtained by (80×mean arterial pressure [mm Hg])/CO. Total peripheral vascular resistance was indexed for body surface area to obtain total peripheral vascular resistance index. 
Renal Function
Statistical Analysis
We used Cox regression analysis to explore the associations between cardiac and obstetric variables and the cumulative incidence of hypertension over a period of 12 years. We defined an event as the occurrence of hypertension during follow-up (yes/no). Time-to-event was defined as the time elapsed between the date of postpartum screening and the date of starting the use of antihypertensive medication or, if not available, by a date halfway the most recent follow-up interval.
Patients who had not developed hypertension at the end of the study period were censored at the end of their follow-up time. Because the amount of missing values in the variables considered for analysis never exceeded 5%, we did not use methods to impute these missing observations. Variables that showed significant associations (P<0.05) in the univariate analysis were included in a multivariate Cox regression model. For the multivariate analysis, we used stepwise backward elimination, on the basis of Wald test, using a P value of 0.05 for elimination of variables. To deal with collinearity, we used only 1 variable if 2 variables measured the same parameter. Variables that remained in the Cox regression model after backward stepwise elimination were used to create subgroups for different Kaplan-Meier analyses. Subjects were stratified according to the presence of the highest risk quartile values versus all other patients. Because of a small percentage (<5%) of missing values in our measurements, numbers at 2, 4, 6, 8, 10, and 12 years could differ between those with BP and those with cardiac ultrasound measurements. Next, we used the log-rank test to test whether the Kaplan-Meier curves were significantly different. All computations were performed using SPSS version 20.0.
Results
Between 1996 and 2008, 652 primiparous women with a history of PE were evaluated. Of the 652 formerly preeclamptic women, 42 (6%) had preexisting hypertension, whereas at the postpartum screening, 133 (20%) were hypertensive and 477 (73%) normotensive ( Figure 1 ). We sent a questionnaire to all normotensive women ≥18 months after the screening and this was repeated every 2 years. A total of 128 women did not return any completed questionnaire, but 349 women responded to ≥1 questionnaire. Of those responders, 322 (92%) remained normotensive, whereas 27 (8%) had developed chronic hypertension during the follow-up. The median follow-up time was 6 (interquartile range, 3-9) years. Also, the 133 women who were hypertensive at postpartum screening received a questionnaire, and 74 responded to ≥1 questionnaire. Of those 74 women who were hypertensive at postpartum screening, 14 did not report the use of antihypertensive medication at follow-up. The total prevalence of chronic hypertension after PE in our population of formerly preeclamptics that responded to a questionnaire is 87/432 (20%). Table 1 shows the baseline characteristics of the women who developed hypertension at follow-up and those who remained normotensive. All women were normotensive at postpartum screening. Women who developed chronic hypertension differed from those who remained normotensive by delivering their child with a lower birth weight at a shorter gestational age. Table 2 lists the hazard ratios of cardiac indices determined at postpartum screening and to what extent these indices were associated with the development of hypertension in the course of the follow-up period. Former patients who had developed hypertension differed from their normotensive counterparts by significantly higher postpartum values for LVM index (LVMi) and IVST, systolic blood pressure, DiasBP, mean arterial pressure, heart rate and BMI, and lower values for E/A ratio. Table 2 also depicts comparable obstetric characteristics in the 2 subgroups.
We selected the 4 most significant variables in the univariate analysis to include in the multivariate analysis. We excluded IVST and mean arterial pressure and BMI from the multivariate analysis to rule out possible collinearity. The remaining variables were LVMi, systolic blood pressure, DiasBP, and E/A ratio. We observed that higher values of LVMi and DiasBP correlated independently with the later development of hypertension. In the subsequent backward stepwise analysis, only the association of LVMi and DiasBP with the development of hypertension remained significant (hazard ratios of 1 ) and DiasBP (≥75 mm Hg). Kaplan-Meier curves ( Figure 2 ) revealed a potential threshold effect for DiasBP and LVMi in the upper Q. After a follow-up time of 10 years, former patients with DiasBP in the fourth Q had a cumulative probability of ≈20% to develop hypertension, which is significantly higher than the probability of 10% of the former patients with a DiasBP below the fourth Q (Figure 2A ). In analogy, women with LVMi in the fourth quartile showed a cumulative probability of >20% to develop hypertension within 10 years, which was also significantly higher than that in former patients with an LVMi below the fourth Q, who had a cumulative probability of only 5% to develop hypertension ( Figure 2B) . Furthermore, Figure 2C shows that when either DiasBP or LVMi is in the fourth Q, the cumulative probability of developing hypertension within 10 years is ≈20%, clearly higher than the close to zero cumulative probability in former patients with neither of these 2 indices in the fourth Q. Finally, Figure 2D shows that when both indices are in the fourth Q, the cumulative risk of developing hypertension within 6 years is >20% compared with 5% when 1 or none of the indices is in the fourth Q. Table 3 shows the demographic and obstetric characteristics of the normotensive former patients who did (responders) and did not respond (nonresponders) to ≥1 completed questionnaire. Both groups were comparable with respect to important prognostic factors. Only the percentage of intrauterine fetal death was borderline significantly higher in the group of nonresponders compared with the group of responders (9% versus 4%, respectively; P=0.06). Groups were compared with the independent t test. Binary variables were tested with the χ 2 . DiasBP indicates diastolic blood pressure; EDV, end-diastolic-volume; ESV, end-systolic-volume; GFR, glomerular filtration rate; IQR, interquartile range; IUFD, intrauterine fetal death; IVST, interventricular septum thickness; LAD, left atrial diameter; LVEDd, left ventricular end-diastolic diameter; LVESd, left ventricular end-systolic diameter; LVM, left ventricular mass; MAP, mean arterial pressure; NA, not applicable; PE, preeclampsia; PP, postpartum; PWT, posterior wall thickness; RWT, relative wall thickness; SGA, small for gestational age; SysBP, systolic blood pressure; and TPVR, total peripheral vascular resistance. 
Discussion
This large and comprehensive long-term study of the postnatal cardiac and hypertensive consequences of preeclampsia highlights the previously underestimated cardiac burden of this pregnancy disorder.
Initially, normotensive formerly preeclamptic women destined to develop hypertension within the next 12 years differ from their counterparts who remain normotensive throughout this period, by increased LVMi and decreased cardiac diastolic function at the time of postpartum screening.
In a normal pregnancy, left ventricular mass and dimensions increase. 4 This eccentric hypertrophy is a healthy physiological response that reverses within few weeks postpartum. 4 In contrast, during PE, women show more pronounced increase in LVM, but with less pronounced LV widening. 4, 13 This concentric hypertrophy develops secondary to the increased LV workload that accompanies the elevated blood pressure.
14 For myocyte growth to support an increased biomechanical load, it must be accompanied by coordinated increases in the surrounding architecture of connective tissue and ground substance that primary consists of collagen. This leads to increased cardiac stiffness, a form of remodeling that reduces the mechanical efficiency of the heart. Hence, it is associated with higher cardiac oxygen demands. Concentric cardiac remodeling is also accompanied by a decline in diastolic function, reflected in larger values for left atrial diameter and circulating atrial natriuretic peptide levels. There is evidence for persisting cardiovascular impairment in the immediate postpartum period. 4, 16 LV hypertrophy in acute PE may have been an adaptive response to minimize wall stress with the sudden development of hypertension in PE. 4, 17 Residual adverse LV altered remodeling might sustain or even progress if high BP persists. 18 Despite the profound effects of PE on the ultrasonic cardiac indices, only few studies explored cardiac function and geometry for an extended postpartum period. It has been reported that normotensive formerly PE women show impaired systolic function 13 to 18 years postpartum, although SV and CO are preserved. 5, 19 Available postpartum data are not completely consistent, most likely as a consequence of the heterogeneous pathogenesis and clinical presentation of PE. 20 Recent guidelines have highlighted the importance of asymptomatic LV dysfunction and hypertrophy in the risk stratification for cardiac disease and heart failure. 21 One year postpartum, mild asymptomatic heart failure is mainly present in women who experienced early-onset PE. 6 These former patients are at increased risk of atrial arrhythmias. 22 The progression from asymptomatic to symptomatic heart failure is associated with a 5-fold increase in the risk of related death, which can be counterbalanced by timely therapeutic intervention. 18 Moreover, even a mildly raised BP is associated with increased LVM. 23 Even in a hypertensive patient, LVM seems to be reversible when BP is lowered at an early stage. 23 Timely identification of women with persisting postpartum structural cardiac abnormalities may contribute to the secondary prevention of more progressed CVD.
On the one hand, we observed a high percentage of women who remained or became hypertensive at time of screening (28%). On the other hand, an additional 8% of initially normotensive women at postpartum screening developed hypertension in later years. The total prevalence of hypertension in our cohort is 36%, a figure which is comparable with reported data 6 and markedly higher than the 3% to 6% prevalence of hypertension in Dutch women between 20 and 39 years. 24 The high prevalence of chronic hypertension in our cohort could be related to the high rate of early-onset PE and preterm PE (73% and 84%, respectively), known to be associated with high risk of developing chronic hypertension and CVD. 2, 6 However, we did not find a significant association of early or preterm PE with the development of later hypertension in initially normotensive women. Perhaps early/preterm PE plays a bigger role in direct postpartum hypertension than in developing later hypertension. Hypertension in the early postpartum period may still normalize over the years, as 14 of 74 initially hypertensive women did not use any antihypertensive medication during follow-up.
The incidence of diabetes mellitus, obtained by self-report, is lower than one would expect in this population. Because we excluded all women that were hypertensive at baseline, we might also have excluded those women that are glucose intolerant because hypertension and glucose intolerance often coexist.
Our large and comprehensive long-term study of the postnatal cardiac and hypertensive consequence of PE, highlighting the significant cardiac burden of this pregnancy disorder, has several limitations. First, we estimated the incidence of hypertension by self-report. On the one hand, this might lead to underestimation of the prevalence of hypertension in subjects who do not regularly check their BP. On the other hand, healthy women are less likely to respond to the questionnaire, which could lead to overestimation. Although these kinds of bias often accompanies such retrospective analyses, the effect might have been minimal because in our study population, medical, demographic, and obstetric characteristics were comparable in responders and nonresponders.
Chronic hypertension may originate from altered circulatory function or adverse metabolic factors jeopardizing endothelial function. On the one hand, 74% of the normotensive women, who went on to develop chronic hypertension, fulfilled the criteria of prehypertension. Prehypertension is defined as a systolic blood pressure ranging from 120 to 139 mm Hg and DiasBP ranging from 80 to 89 mm Hg. 25 Prehypertension is associated with increased CO, total peripheral vascular resistance index, and LVMi. 26 Persistent prehypertension accelerates the development of hypertrophy and diastolic dysfunction of the heart. 27 Moreover, it is associated with an increased risk of myocardial infarction and coronary arterial disease (relative risk of 3.5 [95% CI, 1.6-7.5] and 1.7 [95% CI, 1.2-2.4], respectively). 28 On the other hand, seemingly healthy women may demonstrate unfavorable metabolic and vascular changes. 29 Thus, subclinical risk factors can make women more susceptible to slightly increased BP within the normotensive range, which may manifest as subclinical increase in measures of left ventricular geometry and decreased diastolic function. As such, the Hypertension Writing Group suggests that, although measuring BP remains one of the most important cornerstones of the clinical assessments of patients at risk of hypertension-related CVD, hypertension cannot be classified solely on the basis of discrete blood pressure thresholds and that the levels of BP must be evaluated in the context of the total cardiovascular risk assessment. 25, 30 Our results are in line with our expectations and could also be true in other nonpreeclamptic populations. However, cardiovascular findings related to PE should not be generalized to other subpopulations or the other way around for the following reasons.
First, 1 in 3 women with a history of PE will develop chronic hypertension within 12 years after delivery. Thus, the incidence of chronic hypertension is much higher than in the general population (36% versus 6%). Second, formerly PE patients are seemingly healthy and belong to a fertile and much younger subpopulation (30-40 years) than major other populations with an increased CV risk.
Third, it is debated whether preeclampsia itself is a risk factor for CVD or whether there are additional, more classic risk factors that add on to the risk. There is increasing evidence that PE and CVD do share the same risk factors. Part of these factors can be modified if identified at an early stage. However, it is still not clear to what extent the classic risk factors really add on to the risk of CVD and to what extent modification of these factors decreases the risk.
Conclusions
The development of remote chronic hypertension in initially normotensive formerly preeclamptic women is preceded by increased LVM index and DiasBP at postpartum screening.
Perspectives
Although formerly PE women are at significantly increased risk for premature CVD and despite the fact that they develop CVD at a young age, it is often only recognized at a progressed stage of their disease. Therefore, it is needed to increase the awareness of obstetricians and cardiovascular risk assessors to the early recognizable risk factors that, when identified, can be addressed and perhaps modified.
